Lobe Sciences announces amendment to Altemia acquisition agreement

Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) told investors that it signed an amendment to its April 18, 2023, share purchase agreement to acquire Altemia &...

Related Keywords

,Lobe Sciences Ltd ,Altemia Company ,Sickle Cell Disease ,Transfer Documentation ,